Navigation Links
Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
Date:12/8/2008

Designed to ensure comfort and optimize nutrition for women and their babies

SAN ANTONIO, Dec. 8 /PRNewswire/ -- Mission Pharmacal today announced the addition of CitraNatal(R) Assure to its CitraNatal(R) family of prescription prenatal vitamins. CitraNatal Assure builds on the benefits of the CitraNatal line and offers increased nutrients for women and their babies.

Prenatal vitamins are an important resource for women who are pregnant or planning to become pregnant. They provide women with the essential vitamins and minerals they may be lacking from a healthy diet alone.

"CitraNatal Assure provides women with all the prenatal essentials of the CitraNatal line, and also offers increased levels of several vitamins and minerals," said Neill Walsdorf, Jr., President of Mission Pharmacal. "Mission Pharmacal is proud to add this unique formulation to the CitraNatal family to offer women another prenatal option to meet their individual needs."

CitraNatal Assure contains 300mg of Martek's life'sDHA(TM), a patented, plant-based form of the omega-3 fatty acid DHA, which is consistent with current published guidelines for pregnant and lactating women(1). DHA is the recommended essential fatty acid for prenatal care. It has been shown to be instrumental in the baby's pre- and postnatal brain, eye and nervous system development, increase the baby's gestation period, birth weight and size, lead to higher visual acuity at age 60 days, and increase cognitive and psychomotor developments(2,3,4). DHA cannot be produced naturally by the body; it must be gathered from diet or supplements.

CitraNatal Assure also offers increased levels of iron and vitamin B6. Vitamin B6 contributes to a baby's developing brain and nervous system(5) and may help some women reduce severe nausea or vomiting during pregnancy(6). It also helps the body maintain blood glucose levels, metabolize proteins, formulate neurotransmitters for normal nerve cell communication and makes hemoglobin to carry oxygen to tissues(7).

Pregnant women may experience improved comfort with CitraNatal Assure. CitraNatal Assure contains calcium citrate, a source known for proven absorption and no gas production to help ease GI discomfort during pregnancy, a gentle dual-iron formulation of carbonyl iron and ferrous gluconate for gentle absorption, tolerability and safety, and a stool softener to help ease constipation often associated with pregnancy.

The CitraNatal family of products offers four unique formulations of essential vitamins and minerals designed to ensure comfort and optimize nutrition for women and their babies. Women who are pregnant or planning to conceive should consult with their healthcare provider prior to beginning any prenatal vitamin regimen.

Aboutthe CitraNatal(R) Line

CitraNatal is marketed by Mission Pharmacal Company based in San Antonio, Texas. CitraNatal vitamins are specially formulated for the many women who require nutritional support prior to conception, throughout pregnancy, and during the postnatal period. The plant-derived DHA found in several CitraNatal products is produced exclusively by Martek Biosciences Corporation based in Columbia, Maryland.

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas. For more than 60 years, the company has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them. Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products. For more information, visit www.missionpharmacal.com or www.citranatal.com.

(1) Simopoulos, A.P., et al. Workshop on the Essentiality of and Recommended Dietary Intakes for omega-6 and omega-3 Fatty Acids. Journal of the American College of Nutrition, 1999; 18 (5): 487-489.

(2) Smuts C.M., et al. A Randomized Trial of Docosahexaenoic Acid Supplementation During the Third Trimester of Pregnancy. American College of Obstetrics and Gynecology. 2003;101(3):469-479.

(3) Innis S.M., Friesen R.W. Essential n-3 Fatty Acids in Pregnant Women and Early Visual Acuity Maturation in Term Infants. American Journal of Clinical Nutrition. 2008;87: 548-557.

(4) Jacobson J.L., et al. Beneficial Effects of a Polyunsaturated Fatty Acid on Infant Development: Evidence from the Inuit of Arctic Quebec. The Journal of Pediatrics. 2008;152: 356-364.

(5) Mahomed K., Gulmezoglu A.M. Pyridoxine (vitamin B6) supplementation in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Accessed at: http://drug.pharmacy.psu.ac.th/wbfile/97254611283.doc. Last accessed November 24, 2008.

(6) Sahakian V., et al. Vitamin B6 Is Effective Therapy for Nausea and Vomiting of Pregnancy: A Randomized, Double Blind Placebo-Controlled Study. Obstetrics & Gynecology, 1991; 78(1): 33-36.

(7) Dietary Supplement Fact Sheet: Vitamin B6. Office of Dietary Supplements. National Institutes of Health. Accessed at: http://ods.od.nih.gov/factsheets/vitaminb6.asp. Last accessed November 24, 2008.


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months
2. Alfacell Provides ONCONASE(R) NDA Submission Update
3. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
4. Joint Commission Urges Patients to Speak Up About Pain
5. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
6. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
7. Oregon Tourism Commission Unveils New Online Customer Service Training Program
8. FDA Reviewing Biomoda Submission for Cancer Screening Study
9. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
10. Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
11. Patients Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... , Jan. 17, 2017 Following an ... today praised the Food and Drug Administration,s (FDA,s) ... Human Drug Products by Pharmacies and Outsourcing Facilities." ... proposed limitation on pre-packaging -- which would have ... costs to long term care (LTC) pharmacies.  ...
(Date:1/17/2017)... ReportsnReports.com adds "Anaphylaxis - Pipeline Review, H2 2016" ... Anaphylaxis,s therapeutic pipeline with comprehensive information on the therapeutic development ... assessment by drug target, mechanism of action (MoA), route of ... featured news and press releases. ... Complete report on H2 2016 pipeline ...
Breaking Medicine Technology:
(Date:1/17/2017)... York (PRWEB) , ... January 17, 2017 , ... ... – SightMD – will lecture to primary eye care practitioners on the latest ... at the upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... financial planning assistance to families and business professionals throughout central Colorado, is joining ... homeless families. , The Aurora Warms The Night organization is committed to breaking ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... and breast cancer survivor Sandra Lee as keynote speaker for the 34th Annual ... Florida. , In making the announcement, PER® president, Phil Talamo, said, “We are ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, FloSports , a ... announced a new agreement as part of a long-term extension of their media partnership. ... the airing of some of the sport’s premier events exclusively on FloWrestling.com as well ...
(Date:1/16/2017)... ... ... California Southern University has named Dr. Steven Beazley University President. ... a core faculty member, teaching master’s and doctoral courses in the university’s School of ... where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also has ...
Breaking Medicine News(10 mins):